FDA vaccine safety surveillance system faulty in detecting myocarditis cases

The British Medical Journal reports that the FDA's system for detecting adverse effects of COVID-19 vaccines, specifically myocarditis, was faulty, based on internal communications. This raises concerns about the reliability of vaccine safety monitoring for Pfizer and Moderna doses. The extent of under-detection and its public health implications remain uncertain.